what are Analysts report about Fitbit, Inc.(NYSE:FIT) & Pacific Biosciences of California, Inc.(NASDAQ:PACB)

0
16

Fitbit, Inc. (FIT) will report its next earnings on Feb 25 AMC. The company reported the earnings of $0.04/Share in the last quarter where the estimated EPS by analysts was $-0.01/share. The difference between the expected and actual EPS was $0.05/share, which represents an Earnings surprise of 500%.

Many analysts are providing their Estimated Earnings analysis for Fitbit, Inc. and for the current quarter 11 analysts have projected that the stock could give an Average Earnings estimate of $0.07/share. These analysts have also projected a Low Estimate of $0.04/share and a High Estimate of $0.11/share.

In case of Revenue Estimates, 9 analysts have provided their consensus Average Revenue Estimates for Fitbit, Inc. as 568.16 Million. According to these analysts, the Low Revenue Estimate for Fitbit, Inc. is 560 Million and the High Revenue Estimate is 575 Million. The company had Year Ago Sales of 570.76 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for FIT to be 450%. They are projecting Next Quarter growth of 11.76%. For the next 5 years, Fitbit, Inc. is expecting Growth of 42.41% per annum, whereas in the past 5 years the growth was -7.69% per annum.

Some buy side analysts are also providing their Analysis on Fitbit, Inc., where 2 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 3 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Fitbit, Inc. might touch $10 high while the Average Price Target and Low price Target is $6.63 and $4 respectively.

Fitbit, Inc. closed its last trading session at $6.43 with the gain of 0.31%. The Market Capitalization of the company stands at 1.6 Billion. The Company has 52-week high of $7.79 and 52-week low of $4.23. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 6.02% where SMA50 and SMA200 are 16.75% and 13.07% respectively. The Company Touched its 52-Week High on 06/12/18 and 52-Week Low on 10/29/18.

The Relative Volume of the company is 0.68 and Average Volume (3 months) is 4.67 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -17.4%. The Return on Equity (ROE) value stands at -33.3%. While it’s Return on Investment (ROI) value is -28.9%.

While looking at the Stock’s Performance, Fitbit, Inc. currently shows a Weekly Performance of 4.54%, where Monthly Performance is 13.56%, Quarterly performance is 9.32%, 6 Months performance is 16.01% and yearly performance percentage is 23.8%. Year to Date performance value (YTD perf) value is 29.78%. The Stock currently has a Weekly Volatility of 3.65% and Monthly Volatility of 3.37%.

Pacific Biosciences of California, Inc. (PACB) will report its next earnings on Feb 07 AMC. The company reported the earnings of $-0.19/Share in the last quarter where the estimated EPS by analysts was $-0.15/share. The difference between the expected and actual EPS was $-0.04/share, which represents an Earnings surprise of -26.7%.

Many analysts are providing their Estimated Earnings analysis for Pacific Biosciences of California, Inc. and for the current quarter 5 analysts have projected that the stock could give an Average Earnings estimate of $-0.13/share. These analysts have also projected a Low Estimate of $-0.15/share and a High Estimate of $-0.12/share.

In case of Revenue Estimates, 4 analysts have provided their consensus Average Revenue Estimates for Pacific Biosciences of California, Inc. as 21.14 Million. According to these analysts, the Low Revenue Estimate for Pacific Biosciences of California, Inc. is 18.35 Million and the High Revenue Estimate is 23.9 Million. The company had Year Ago Sales of 24.93 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for PACB to be 27.8%. They are projecting Next Quarter growth of 45%. For the next 5 years, Pacific Biosciences of California, Inc. is expecting Growth of 27.94% per annum, whereas in the past 5 years the growth was 21.84% per annum.

Some buy side analysts are also providing their Analysis on Pacific Biosciences of California, Inc., where 0 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 1 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Pacific Biosciences of California, Inc. might touch $8 high while the Average Price Target and Low price Target is $8 and $8 respectively.

Pacific Biosciences of California, Inc. closed its last trading session at $7.15 with the loss of -0.98%. The Market Capitalization of the company stands at 1.06 Billion. The Company has 52-week high of $7.84 and 52-week low of $2.02. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is -0.74% where SMA50 and SMA200 are -3.61% and 43.14% respectively. The Company Touched its 52-Week High on 11/30/18 and 52-Week Low on 04/02/18.

The Relative Volume of the company is 0.54 and Average Volume (3 months) is 2.48 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -59.6%. The Return on Equity (ROE) value stands at -91.1%. While it’s Return on Investment (ROI) value is -90.1%.

While looking at the Stock’s Performance, Pacific Biosciences of California, Inc. currently shows a Weekly Performance of 2.31%, where Monthly Performance is -3.93%, Quarterly performance is -8.65%, 6 Months performance is 78.34% and yearly performance percentage is 172.31%. Year to Date performance value (YTD perf) value is -4.32%. The Stock currently has a Weekly Volatility of 2.38% and Monthly Volatility of 2.02%.

SHARE